VEXAS patients typically exhibit variants in codon 41 of UBA1, leading to an amino acid substitution in UBA1a, disruption of UBA1b expression, and instead the expression of a truncated isoform, UBA1c, with reduced catalytic activity [1]. This evidence concerns the gene UBA1 and VEXAS syndrome.